Information  X 
Enter a valid email address

XTL Biopharm Ltd (XTL)

  Print      Mail a friend

Thursday 19 December, 2002

XTL Biopharm Ltd

Director Shareholding

XTL Biopharmaceuticals Limited
19 December 2002

                                  SCHEDULE 11

1      Name of Company

       XTL Biopharmaceuticals Ltd
2      Name of Director

       Geoffrey Vernon c/o Ziggus Holdings Ltd
3      Please state whether notification indicates that it is in respect of holding of the shareholder named
       in 2 above or in respect of a non beneficial interest or in the case of an individual holder if it is
       a holding of that person's spouse or children under the age of 18 or in respect of a non-beneficial

       As 2 Above
4      Name of the registered holder(s) and, if more than one holder, the number of shares held by each of
       them (if notified)
       As 2 Above
5      Please state whether notification relates to a person(s) connected with the Director named in 2 above
       and identify the connected person(s)
       As 2 Above
6      Please state the nature of the transaction. For PEP transactions please indicate whether general/
       single co PEP and if discretionary/non discretionary

       Market Purchase
7      Number of shares/amount of Stock acquired
8      Percentage of issued class
9      Number of shares/amount of stock disposed
10     Percentage of issued class
11     Class of security
12     Price per share
13     Date of transaction
       19 December 2002
14     Date company informed
       19 December 2002
15     Total holding following this notification
16     Total percentage holding of issued class following this notification
       If a director has been granted options by the company please complete the following boxes

17     Date of grant

18     Period during which or date on which exercisable

19     Total amount paid (if any) for grant of the option

20     Description of shares or debentures involved: class, number

21     Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise

22     Total number of shares or debentures over which options held following this notification

23     Any additional information

24     Name of contact and telephone number for queries

       Jonathan Burgin +972 8940 5134
25     Name and signature of authorised company official responsible for making this notification

       Jonathan Burgin
26     Date of Notification

       19 December 2002

                      This information is provided by RNS
            The company news service from the London Stock Exchange